Venous thrombosis Flashcards
Describe the characteristics of venous thrombosis?
low pressure system
platelets not activated
activated coagulation cascade so clots rich in fibrin
How do you treat venous thrombosis? (3)
heparin
Warfarin
new oral anticoagulants
these interfere with secondary haemostasis
clinical signs of:
- DVT?
- PE?
-limb feels hot, swollen, tender
pitting oedema
-Pulmonary infarction causing pleuritic chest pain
CV collapse and death
hypoxia
R heart strain
What are the risk factors for venous thromboembolism?
-what is hypercoagulability associated with?
changes in: stasis, vessel wall, hypercoaguability
Age Marked obesity Pregnancy puerperium Oestrogen therapy Previous DVT/PE Trauma/surgery malignancy Paralysis Infection Thrombophilia
-release of tissue factor, raised vWF and factor VIII
Thrombophilia
- what is it?
- give the potential mechanisms by which this occurs?
-familial or acquired disorders of the haemostatic mechanism which are likely to predispose to thrombosis
-inc coagulation activity: platelet plug formation and fibrin clot formation
Dec fibrinolytic activity
Dec anticoagulant activity (most common) e.g. deficiency in antithrombin protein C & protein S
Hereditary thrombophilias
- what are they?
- name 5
- when should screening be considered?
- management
-group of genetic defects in which affected individuals have an inc tendency codevelop premature, unusual and recurrent thromboses
-Factoe V Leiden Prothrombin 20210 mutation antithrombin deficiency protein C deficiency Protein S deficiency *dont increase risk of venous thrombosis*
-VT <45 recurrent VT unusual VT Fam hx of venous thrombosis Fam hx of thrombophilia
-advice on avoiding risk
short term prophylaxis
short term anticoagulation
long term anticoagulation if recurrent events
How do you asses the need for long term anticoagulation?
- first episode?
- second?
- how do you asses risk of recurrent thrombosis?
Risk of recurrent thrombosis balanced with
Risk of serious haemorrhage
- anticoagulate for 6 months
- lifelong anticoagulation
-Hx prev thrombosis
spontaneous= greater risk than acquired
family hx
Thrombophilia screen
Acquired thrombophilia: antiphospholipid antibody syndrome
- features?
- describe the pathogenesis?
- name the antibodies involved and their effect on the APTT?
- associated with which conditions?
- treatment?
-recurrent thromboses at young age
Arterial & venous
recurrent foetal loss
Mild thrombocytopenia
- antibodies lead to conformational change in Bets 2 glycoprotein 1 which leads to activation of both primary and secondary haemostasis and vessel wall abnormalities
- autoantibodies with specificity for anionic phospholipids and which prolong phospholipid dependant coagulation tests in vitro- lupus anticoagulants
- Autoimmune, Lymphoproliferative disorders, Viral infections, drugs, primary
-Give treatment depending on thrombotic events
Aspirin- arterial
warfarin- venous